FRAGMENT 176-191, frag 176 191, fragment176-191

Fragment 176-191 is a modified peptide derived from the human growth hormone (HGH) amino acid chain, designed to focus specifically on fat-loss activity without the full effects of HGH. In research settings, it is known for promoting lipolysis (fat breakdown), reducing lipogenesis, and supporting body-composition improvements. Because it targets the hormone’s fat-metabolizing region only, Fragment 176-191 is popular in studies exploring weight-management, metabolic regulation, and energy balance, while avoiding the broader systemic actions associated with full-length HGH.